Camber Pharma launches generic Emend
PISCATAWAY, N.J. – Camber Pharmaceuticals announces the addition of fosaprepitant for injection to their current portfolio. Fosaprepitant for injection is indicated in adults for the prevention of: • acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin. • delayed nausea and vomiting associated with initial
